title: Cutting edge: homologous recombination of the MHC class I K region defines new MHC-linked diabetogenic susceptibility gene(s) in nonobese diabetic mice.
abstract: To localize the MHC-linked diabetogenic genes in the nonobese diabetic (NOD) mouse, a recombinational hotspot from the B10.A(R209) mouse was introduced to the region between the MHC class I K and class II A of the NOD mouse with the recombinational site centromeric to the Lmp2/Tap1 complex by breeding the two strains. Replacement of the NOD region centromeric to the recombinational site with the same region in R209 mice prevented the development of diabetes (from 71 to 3%) and insulitis (from 61 to 15%) in the N7 intra-MHC recombinant NOD mice. Similarly, the replacement of the NOD class II A, E and class I D region with the same region in R209 mice prevented the diseases (diabetes, from 71 to 0%; insulitis, from 61 to 3%). In addition to the MHC class II genes, there are at least two MHC-linked diabetogenic genes in the region centromeric to Lmp2.
authors.affiliation: Section on Immunology and Immunogenetics, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA. hattorium@joslab.harvard.edu
authors.forename: M
authors.initials: M
authors.lastname: Hattori
authors.forename: E
authors.initials: E
authors.lastname: Yamato
authors.forename: N
authors.initials: N
authors.lastname: Itoh
authors.forename: H
authors.initials: H
authors.lastname: Senpuku
authors.forename: T
authors.initials: T
authors.lastname: Fujisawa
authors.forename: M
authors.initials: M
authors.lastname: Yoshino
authors.forename: M
authors.initials: M
authors.lastname: Fukuda
authors.forename: E
authors.initials: E
authors.lastname: Matsumoto
authors.forename: T
authors.initials: T
authors.lastname: Toyonaga
authors.forename: I
authors.initials: I
authors.lastname: Nakagawa
authors.forename: M
authors.initials: M
authors.lastname: Petruzzelli
authors.forename: A
authors.initials: A
authors.lastname: McMurray
authors.forename: H
authors.initials: H
authors.lastname: Weiner
authors.forename: T
authors.initials: T
authors.lastname: Sagai
authors.forename: K
authors.initials: K
authors.lastname: Moriwaki
authors.forename: T
authors.initials: T
authors.lastname: Shiroishi
authors.forename: R
authors.initials: R
authors.lastname: Maron
authors.forename: T
authors.initials: T
authors.lastname: Lund
mesh_terms: D000818:Animals; D002503:Centromere / Q000235:genetics / Q000276:immunology; D003433:Crosses, Genetic; D003546:Cysteine Endopeptidases; D003922:Diabetes Mellitus, Type 1 / Q000453:epidemiology / Q000235:genetics* / Q000276:immunology / Q000473:pathology; D005260:Female; D008040:Genetic Linkage / Q000276:immunology; D020022:Genetic Predisposition to Disease / Q000276:immunology*; D006183:H-2 Antigens / Q000235:genetics*; D015994:Incidence; D007515:Islets of Langerhans / Q000473:pathology; D008285:Major Histocompatibility Complex / Q000235:genetics*; D008297:Male; D051379:Mice; D020297:Mice, Congenic; D008805:Mice, Inbred A; D008810:Mice, Inbred C57BL; D016688:Mice, Inbred NOD; D011506:Proteins / Q000235:genetics; D011995:Recombination, Genetic / Q000276:immunology*; D016615:Telomere / Q000235:genetics / Q000276:immunology
chemical_list: D006183:H-2 Antigens; C024755:H-2K(K) antigen; D011506:Proteins; C071313:LMP-2 protein; D003546:Cysteine Endopeptidases